natura-alpha (TAK-114)
/ Natrogen Therap, Takeda
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 04, 2016
Takeda: Q3 FY 2015 Results
(Takeda)
- Discontinued in ulcerative colitis due to potential for a better product profile with a similar candidate compound
Discontinued • Immunology • Inflammatory Bowel Disease
1 to 1
Of
1
Go to page
1